Mgit 960
The MGIT 960 is a laboratory instrument designed for the automated detection and identification of mycobacteria in clinical samples. It utilizes liquid culture technology to rapidly detect the presence of mycobacteria, including Mycobacterium tuberculosis, in a controlled and efficient manner.
Lab products found in correlation
111 protocols using mgit 960
Automated Mycobacterium Tuberculosis PZA Susceptibility
Phenotypic testing for TB drug resistance
Mycobacterium tuberculosis Isolation and Sensitivity
“Time to positivity” (TTP) was defined as the number of days from MGIT inoculation to the positive culture result using Epicenter software (Becton Dickinson). An aliquot of 500 μl was tested with Xpert MTB/RIF assay (Xpert, Cepheid, USA) according to manufacturer’s instruction. An aliquot of 500 μl was stored at -20 °C for further use; when culture results were available, only MTB-positive aliquots were archived at -20 °C while the MTB-negative aliquots were discarded.
Mycobacterium tuberculosis Drug Susceptibility Testing
Evaluating GenoType MTBDR plus for Drug Resistance
Relevant publications were excluded if they were duplicated articles, letters without original data, case reports, editorials, and reviews. Studies with fewer than 10 samples were also excluded to reduce selection bias.
Diagnostic Accuracy of SAT-TB and Acid-Fast Staining
Characterization of M. tuberculosis Isolates
Molecular Analysis of Drug-Resistant Tuberculosis
The study was approved by the Ethics Committee of the Moscow Government Health Department. The Ethics Committee waived the need for patient consent because the study did not include personal identifiers or clinical data and the samples were analyzed anonymously.
Linezolid-based Treatment for Drug-resistant Spinal TB
The indication for the administration of a linezolid-containing regimen prior to surgery was the suspected drug-resistant TB in the patients. The indication of suspected drug-resistant TB was failure of first-line anti-TB treatment regimen. After the operation, the anti-TB treatment regimen was adjusted based on the results of Xpert MTB/RIF and drug sensitivity testing. If the patient showed no resistance to rifampicin, then linezolid was discontinued.
Evaluating CF's Impact on M. tuberculosis Detection
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!